Ivermectin as a Treatment Modality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Up-To-Date RCTs

Ivermectin as a Treatment Modality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Up-To-Date RCTs

The objective of this systematic review and meta-analysis is to assess the efficacy and safety of Ivermectin compared to placebo or standard of care for the treatment and prevention of COVID-19 disease. Literature search was carried out in PubMed, Scopus, and google scholar. Clinical trial registrie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Raghava Kalyan Maddukuri, Madhavi Latha Desimalla, Reshma Banavathu, Sai Pavan Kumar Arepalli
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-01-01
Series:	Indian Journal of Community Medicine
Subjects:	covid-19 grade ivermectin meta-analysis
Online Access:	https://journals.lww.com/10.4103/ijcm.ijcm_117_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of ivermectin on scabies: a retrospective evaluation
by: Ömer Karakoyun, et al.
Published: (2025-07-01)

CLINICAL AND HISTOPATHOLOGICAL INVESTIGATION OF IVERMECTIN TOXICITY IN PIGEONS
by: Waleed M. S
Published: (2010-06-01)

Evaluation of the Photostability of Ivermectin
by: Franklin Vargas, et al.
Published: (2024-11-01)

Comparison of Safety Of Oral Ivermectin with Topical Permethrin in the Treatment of Scabies: A Comparative Study
by: Rishab Dev Tripathee, et al.
Published: (2024-04-01)

Comparison of Safety Of Oral Ivermectin with Topical Permethrin in the Treatment of Scabies: A Comparative Study
by: Rishab Dev Tripathee, et al.
Published: (2024-04-01)

Appraising Onchocerciasis Community Directed Treatment with Ivermectin: Problems, Progress and Prospects
by: Osue H.O.*
Published: (2023-06-01)

Effectiveness of Ivermectin treatment among adult patients infected with Strongyloides stercoralis in East Gojam zone, Northwest Ethiopia
by: Gashaw Azanaw Amare, et al.
Published: (2025-05-01)

HISTOPATHOLOGICAL AND BIOCHEMICAL EFFECTS OF IVERMECTIN ON KIDNEY FUNCTIONS, LUNG AND THE AMELIORATIVE EFFECTS OF VITAMIN C IN RABBITS (Lupus cuniculus)
by: Khawla Bedan Al-Jassim, et al.
Published: (2015-11-01)

Quantitative Determination of Ivermectin in Polymer Microspheres
by: A. I. Mogaibo, et al.
Published: (2022-02-01)

Community acceptance of Ivermectin mass drug administration for malaria in Southern Thailand
by: Pyae Linn Aung, et al.
Published: (2025-08-01)

Ivermectin and Gynecologic Cancer: What are the data?
by: Vaidehi Mujumdar, et al.
Published: (2025-08-01)

Kinetics and dynamics of ivermectin removal from sheep organism after using iverlong
by: E. S. Engasheva, et al.
Published: (2016-05-01)

Estimation of embryotoxic and teratogenic effects of ivermectin in laboratory animals
by: N. B. Yemelyanova, et al.
Published: (2016-05-01)

First report of ivermectin resistance in natural infected Foals by Parascaris spp. in Tiaret, Algeria
by: Ammar Selles Sidi Mohammed, et al.
Published: (2025-01-01)

Comparative susceptibility of wild and laboratory-reared Aedes and Anopheles larvae to ivermectin
by: Cheick Oumar W. Ouédraogo, et al.
Published: (2025-07-01)

Effects of ivermectin, phoxim and propetamphos+cypermethrin combination against sarcoptic mange in new zealand rabbits
by: Bilal Dik, et al.

Direct and Indirect Effects of Ivermectin on Phytophagous, Frugivorous and Parasitoid Insects
by: Lars Laber, et al.
Published: (2025-04-01)

Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
by: O. I. Rybchenko, et al.
Published: (2022-05-01)

Association between ivermectin treatment and mortality in COVID-19: A hospital-based case-control study
by: Ravi Kirti, et al.
Published: (2023-01-01)

Ivermectin inhibits the growth of ESCC by activating the ATF4-mediated endoplasmic reticulum stress-autophagy pathway
by: Liu Huiyang, et al.
Published: (2024-11-01)

The efficacy and safety of minocycline, metronidazole, ivermectin, and azelaic acid in moderate-to-severe papulopustular rosacea: A systematic review and network meta-analysisCapsule Summary
by: Esraa A. Shaheen, MD, et al.
Published: (2025-06-01)

Ivermectin as a promising therapeutic option for onchocerciasis‐associated epilepsy
by: Mohammad Amin Manavi, et al.
Published: (2025-02-01)

Residue depletion profile and withdrawal interval estimation of ivermectin in eggs following topical administration of injectable ivermectin to domestic chickens (Gallus domesticus): a pilot study
by: Melissa A. Mercer, et al.
Published: (2025-02-01)

The elimination period of ivermectin residuals from the body of broiler chickens after Iverbutan
by: E. N. Indyuhova, et al.
Published: (2022-09-01)

Cytotoxic effects of ivermectin on Giardia lamblia: induction of apoptosis and cell cycle arrest
by: Florencia Nicole Barzola, et al.
Published: (2024-10-01)

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
by: Guilherme Dias de Melo, et al.
Published: (2021-07-01)

Role of ivermectin and colchicine in the treatment of COVID-19: a randomized controlled clinical trial
by: Hemmat Abd El-Salam Ahmed Salama, et al.
Published: (2024-12-01)

Collateral benefits of ivermectin mass drug administration designed for malaria against headlice in Mopeia, Mozambique: a cluster randomised controlled trial
by: Joanna Furnival-Adams, et al.
Published: (2025-03-01)

Context‐Dependent Effects of Ivermectin Residues on Dung Insects: Interactions With Environmental Stressors, Size, and Sex in a Sepsid Fly (Sepsis neocynipsea)
by: Jill Walker, et al.
Published: (2025-08-01)

Assessing the effect of orally administered Ivermectin on viremia and shedding of porcine reproductive and respiratory syndrome virus in growing pigs under field conditions
by: Grant Allison, et al.
Published: (2025-07-01)

UBR-1 deficiency leads to ivermectin resistance in Caenorhabditis elegans
by: Yi Li, et al.
Published: (2025-04-01)

Ivermectin Attenuates Methotrexate-Induced Liver Fibrosis by Reducing TGF-β and Syndecan-1 Expression
by: Cengiz Dibekoğlu, et al.
Published: (2025-06-01)

Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Trichuris incognita Species with Low Sensitivity to Albendazole/Ivermectin Combination Treatment
by: Abhinaya Venkatesan, et al.
Published: (2025-01-01)

A comparative parasitological, histopathological, and proteomic analysis of Schistosoma mansoni infected mice treated with ivermectin and praziquantel
by: Eman Sayed El-Wakil, et al.
Published: (2025-07-01)

Untreated villages and factors associated with the absence of Community-Directed Treatment with Ivermectin (CDTI) in DRC
by: Jean-Claude Makenga Bof, et al.
Published: (2018-09-01)

Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya
by: Truphena Onyango, et al.
Published: (2025-03-01)

Evaluating the corrosion inhibition potential of expired ivermectin drug on mild steel: A comprehensive multi-method investigation
by: Jeetendra Bhawsar, et al.
Published: (2025-06-01)

Testing ivermectin-based solid dispersion preparations obtained by different techniques against parasitic diseases of domestic animals
by: M. B. Musaev, et al.
Published: (2025-06-01)

Toxicity of ivermectin to bed bugs (Cimex hemipterus) and risk factors associated with infestation in Kwale County, coastal Kenya
by: Tobias Odongo, et al.
Published: (2025-07-01)

Development and validation of a RP-HPLC method for the quantization studies of ivermectin in solutions dosage forms
by: Elena Gabriela Oltean,, et al.
Published: (2011-12-01)